Novavax updates plans for stock and debt offerings as its share price continues sinking


The vaccine maker’s share price ascended as high as $331.68 during the Covid-19 pandemic.

Previous SBA lending in the Albany region: More loans, but lower volume
Next How a health care pioneer GenapSys unraveled